Pinho, Marcos D.
Erol, Erdal
Ribeiro-Gonçalves, Bruno
Mendes, Catarina I.
Carriço, João A.
Matos, Sandra C.
Preziuso, Silvia
Luebke-Becker, Antina
Wieler, Lothar H.
Melo-Cristino, Jose
Ramirez, Mario
Article History
Received: 24 May 2016
Accepted: 25 July 2016
First Online: 17 August 2016
Competing interests
: Dr. José Melo-Cristino has received research grants administered through his university and received honoraria for serving on the speakers bureaus of Pfizer, Bial, GlaxoSmithKline and Novartis. Dr Mário Ramirez has received honoraria for serving on speakers bureau of Pfizer and for consulting from GlaxoSmithKline. The other authors declare no conflict of interest. No company or financing body had any interference in the decision to publish.